Page last updated: 2024-12-08

gamma-lumicolchicine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID244898
CHEMBL ID527025
CHEBI ID93737
SCHEMBL ID13673747
MeSH IDM0012731

Synonyms (29)

Synonym
MLS002153821
smr001233190
BRD-K99411983-001-02-3
PRESTWICK3_000453
nsc-56233
lumicolchicine
NSC56233 ,
PRESTWICK_307
lumicolchicine gamma
NCGC00179531-01
BSPBIO_000526
BPBIO1_000580
CHEMBL527025
HMS2096K08
HMS2231J20
(7s-(7alpha,7bbeta,10abeta))-n-(5,6,7,7b,8,10a-hexahydro-1,2,3,9-tetramethoxy-8-oxobenzo(a)cyclopenta(3,4)cyclobuta(1,2-c)cyclohepten-7-yl)acetamide
SCHEMBL13673747
AC-30175
mfcd00151110
CHEBI:93737
[7s-(7alpha,7bbeta,10abeta)]-n-(5,6,7,7b,8,10a-hexahydro-1,2,3,9-tetramethoxy-8-oxobenzo[a]cyclopenta[3,4]cyclobuta[1,2-c]cyclohepten-7-yl)acetamide
beta-lumicolchicin
AKOS032947213
Q27165431
lsm-4236
n-[(10s,12r,16s)-3,4,5,14-tetramethoxy-13-oxo-10-tetracyclo[9.5.0.02,7.012,16]hexadeca-1(11),2,4,6,14-pentaenyl]acetamide
n-[(7s,7br,10as)-1,2,3,9-tetramethoxy-8-oxo-5,6,7,7b,8,10a-hexahydrobenzo[a]cyclopenta[3,4]cyclobuta[1,2-c]cyclohepten-7-yl]acetamide (beta-lumicolchicine)
n-[(10r,12s,16r)-3,4,5,14-tetramethoxy-13-oxo-10-tetracyclo[9.5.0.02,7.012,16]hexadeca-1(11),2,4,6,14-pentaenyl]acetamide
?-lumi (-)-colchicine

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
"5 mg/kg dosage had no significant effects."( The effects of colchicine on prostaglandin I2 and thromboxane A2 biosynthesis in the rat dental pulp.
Hirafuji, M; Ogura, Y, 1988
)
0.27
" Dose-response curves (DRCs) to the pigment-concentrating hormone PCH were determined under control and experimental conditions to evaluate the effects elicited by the cytoskeleton-affecting drugs."( Cytoskeleton and PCH-induced pigment aggregation in Macrobrachium potiuna erythrophores.
Castrucci, AM; Josefsson, L; Tuma, MC, 1995
)
0.29
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (3)

ClassDescription
carbotricyclic compoundA carbopolyclic compound comprising of three carbocyclic rings.
acetamidesCompounds with the general formula RNHC(=O)CH3.
alkaloidAny of the naturally occurring, basic nitrogen compounds (mostly heterocyclic) occurring mostly in the plant kingdom, but also found in bacteria, fungi, and animals. By extension, certain neutral compounds biogenetically related to basic alkaloids are also classed as alkaloids. Amino acids, peptides, proteins, nucleotides, nucleic acids, amino sugars and antibiotics are not normally regarded as alkaloids. Compounds in which the nitrogen is exocyclic (dopamine, mescaline, serotonin, etc.) are usually classed as amines rather than alkaloids.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (2)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
chromobox protein homolog 1Homo sapiens (human)Potency79.43280.006026.168889.1251AID540317
gemininHomo sapiens (human)Potency0.32640.004611.374133.4983AID624297
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (27)

Assay IDTitleYearJournalArticle
AID377078Antimicrobial activity against Saccharomyces cerevisiae after 3 days2005Journal of natural products, Feb, Volume: 68, Issue:2
New colchicinoids from a native Jordanian meadow saffron, colchicum brachyphyllum: isolation of the first naturally occurring dextrorotatory colchicinoid.
AID377079Antimicrobial activity against Aspergillus niger after 3 days2005Journal of natural products, Feb, Volume: 68, Issue:2
New colchicinoids from a native Jordanian meadow saffron, colchicum brachyphyllum: isolation of the first naturally occurring dextrorotatory colchicinoid.
AID1668779Effect on alpha-tublin parameters in Parkinson's disease patient derived human ONS cells at 10 uM after 24 hrs by anti-alphatubulin staining based fluorescence assay2020Journal of natural products, 05-22, Volume: 83, Issue:5
A Grand Challenge. 3. Unbiased Phenotypic Function of Metabolites from Australia Plants
AID1668780Effect on mitochondria parameters in Parkinson's disease patient derived human ONS cells at 10 uM after 24 hrs by MitoTracker Orange CMTMRos staining based fluorescence assay2020Journal of natural products, 05-22, Volume: 83, Issue:5
A Grand Challenge. 3. Unbiased Phenotypic Function of Metabolites from Australia Plants
AID377077Antimicrobial activity against Mycobacterium smegmatis after 3 days2005Journal of natural products, Feb, Volume: 68, Issue:2
New colchicinoids from a native Jordanian meadow saffron, colchicum brachyphyllum: isolation of the first naturally occurring dextrorotatory colchicinoid.
AID377076Antimicrobial activity against Micrococcus luteus after 3 days2005Journal of natural products, Feb, Volume: 68, Issue:2
New colchicinoids from a native Jordanian meadow saffron, colchicum brachyphyllum: isolation of the first naturally occurring dextrorotatory colchicinoid.
AID377073Cytotoxicity against human H460 after 3 days by SRB assay2005Journal of natural products, Feb, Volume: 68, Issue:2
New colchicinoids from a native Jordanian meadow saffron, colchicum brachyphyllum: isolation of the first naturally occurring dextrorotatory colchicinoid.
AID377072Cytotoxicity against human MCF7 after 3 days by SRB assay2005Journal of natural products, Feb, Volume: 68, Issue:2
New colchicinoids from a native Jordanian meadow saffron, colchicum brachyphyllum: isolation of the first naturally occurring dextrorotatory colchicinoid.
AID377074Cytotoxicity against human SF-268 after 3 days by SRB assay2005Journal of natural products, Feb, Volume: 68, Issue:2
New colchicinoids from a native Jordanian meadow saffron, colchicum brachyphyllum: isolation of the first naturally occurring dextrorotatory colchicinoid.
AID1668777Cytotoxicity against Parkinson's disease patient derived human ONS cells assessed as effect on nucleus morphology parameters at 10 uM after 24 hrs by DAPI staining based fluorescence assay2020Journal of natural products, 05-22, Volume: 83, Issue:5
A Grand Challenge. 3. Unbiased Phenotypic Function of Metabolites from Australia Plants
AID1668781Effect on autophagosome in Parkinson's disease patient derived human ONS cells assessed as LC3b parameters at 10 uM after 24 hrs by anti-LC3b 1/335 staining based fluorescence assay2020Journal of natural products, 05-22, Volume: 83, Issue:5
A Grand Challenge. 3. Unbiased Phenotypic Function of Metabolites from Australia Plants
AID1668778Cytotoxicity against Parkinson's disease patient derived human ONS cells assessed as effect on cell morphology parameters at 10 uM after 24 hrs by DAPI staining based fluorescence assay2020Journal of natural products, 05-22, Volume: 83, Issue:5
A Grand Challenge. 3. Unbiased Phenotypic Function of Metabolites from Australia Plants
AID377075Toxicity in brine shrimp2005Journal of natural products, Feb, Volume: 68, Issue:2
New colchicinoids from a native Jordanian meadow saffron, colchicum brachyphyllum: isolation of the first naturally occurring dextrorotatory colchicinoid.
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (38)

TimeframeStudies, This Drug (%)All Drugs %
pre-199011 (28.95)18.7374
1990's15 (39.47)18.2507
2000's6 (15.79)29.6817
2010's4 (10.53)24.3611
2020's2 (5.26)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.57

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.57 (24.57)
Research Supply Index3.71 (2.92)
Research Growth Index4.28 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.57)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other40 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]